Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 144 Pages
Report ld: 6893180
Request Sample
Customized Report
The global market for Salvianolic Acid A was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Salvianolic acid A is a phenolic acid, isolated from Danshen, a traditional Chinese medicine, commonly used for the treatment of bone loss, chronic renal failure, hepatocirrhosis, hepatitis, coronary heart disease and cerebrovascular disease.
The North American market for Salvianolic Acid A was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Salvianolic Acid A was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Salvianolic Acid A was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Salvianolic Acid A market include Santa Cruz Biotechnology, Merck, Cayman Chemical, LGC, Adooq Bioscience, Selleck Chemicals, AbMole, Ark Pharm, Clearsynth, Biosynth Carbosynth, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Salvianolic Acid A, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Salvianolic Acid A market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Salvianolic Acid A.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Salvianolic Acid A manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Salvianolic Acid A sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Salvianolic Acid A sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Salvianolic Acid A Product Introduction
1.2 Global Salvianolic Acid A Market Size Forecast
1.2.1 Global Salvianolic Acid A Sales Value (2021–2032)
1.2.2 Global Salvianolic Acid A Sales Volume (2021–2032)
1.2.3 Global Salvianolic Acid A Sales Price (2021–2032)
1.3 Salvianolic Acid A Market Trends & Drivers
1.3.1 Salvianolic Acid A Industry Trends
1.3.2 Salvianolic Acid A Market Drivers & Opportunities
1.3.3 Salvianolic Acid A Market Challenges
1.3.4 Salvianolic Acid A Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Salvianolic Acid A Players Revenue Ranking (2025)
2.2 Global Salvianolic Acid A Revenue by Company (2021–2026)
2.3 Global Salvianolic Acid A Sales Volume Ranking of Players (2025)
2.4 Global Salvianolic Acid A Sales Volume by Company (2021–2026)
2.5 Global Salvianolic Acid A Average Price by Company (2021–2026)
2.6 Key Manufacturers Salvianolic Acid A Manufacturing Base and Headquarters
2.7 Key Manufacturers Salvianolic Acid A Product Offerings
2.8 Key Manufacturers Start of Mass Production of Salvianolic Acid A
2.9 Salvianolic Acid A Market Competitive Analysis
2.9.1 Salvianolic Acid A Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Salvianolic Acid A Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Salvianolic Acid A revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Salvianolic Acid A Market Classification
3.1 Introduction by Type
3.1.1 Min Purity Less Than 98%
3.1.2 Min Purity 98%-99%
3.1.3 Min Purity More Than 99%
3.1.4 Global Salvianolic Acid A Sales Value by Type
3.1.4.1 Global Salvianolic Acid A Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Salvianolic Acid A Sales Value, by Type (2021–2032)
3.1.4.3 Global Salvianolic Acid A Sales Value, by Type (%), 2021–2032
3.1.5 Global Salvianolic Acid A Sales Volume by Type
3.1.5.1 Global Salvianolic Acid A Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Salvianolic Acid A Sales Volume, by Type (2021–2032)
3.1.5.3 Global Salvianolic Acid A Sales Volume, by Type (%), 2021–2032
3.1.6 Global Salvianolic Acid A Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research
4.1.2 Medical
4.2 Global Salvianolic Acid A Sales Value by Application
4.2.1 Global Salvianolic Acid A Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Salvianolic Acid A Sales Value, by Application (2021–2032)
4.2.3 Global Salvianolic Acid A Sales Value, by Application (%), 2021–2032
4.3 Global Salvianolic Acid A Sales Volume by Application
4.3.1 Global Salvianolic Acid A Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Salvianolic Acid A Sales Volume, by Application (2021–2032)
4.3.3 Global Salvianolic Acid A Sales Volume, by Application (%), 2021–2032
4.4 Global Salvianolic Acid A Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Salvianolic Acid A Sales Value by Region
5.1.1 Global Salvianolic Acid A Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Salvianolic Acid A Sales Value by Region (2021–2026)
5.1.3 Global Salvianolic Acid A Sales Value by Region (2027–2032)
5.1.4 Global Salvianolic Acid A Sales Value by Region (%), 2021–2032
5.2 Global Salvianolic Acid A Sales Volume by Region
5.2.1 Global Salvianolic Acid A Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Salvianolic Acid A Sales Volume by Region (2021–2026)
5.2.3 Global Salvianolic Acid A Sales Volume by Region (2027–2032)
5.2.4 Global Salvianolic Acid A Sales Volume by Region (%), 2021–2032
5.3 Global Salvianolic Acid A Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Salvianolic Acid A Sales Value, 2021–2032
5.4.2 North America Salvianolic Acid A Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Salvianolic Acid A Sales Value, 2021–2032
5.5.2 Europe Salvianolic Acid A Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Salvianolic Acid A Sales Value, 2021–2032
5.6.2 Asia Pacific Salvianolic Acid A Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Salvianolic Acid A Sales Value, 2021–2032
5.7.2 South America Salvianolic Acid A Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Salvianolic Acid A Sales Value, 2021–2032
5.8.2 Middle East & Africa Salvianolic Acid A Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Salvianolic Acid A Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Salvianolic Acid A Sales Value and Sales Volume
6.2.1 Key Countries/Regions Salvianolic Acid A Sales Value, 2021–2032
6.2.2 Key Countries/Regions Salvianolic Acid A Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Salvianolic Acid A Sales Value, 2021–2032
6.3.2 United States Salvianolic Acid A Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Salvianolic Acid A Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Salvianolic Acid A Sales Value, 2021–2032
6.4.2 Europe Salvianolic Acid A Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Salvianolic Acid A Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Salvianolic Acid A Sales Value, 2021–2032
6.5.2 China Salvianolic Acid A Sales Value by Type (%), 2025 vs 2032
6.5.3 China Salvianolic Acid A Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Salvianolic Acid A Sales Value, 2021–2032
6.6.2 Japan Salvianolic Acid A Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Salvianolic Acid A Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Salvianolic Acid A Sales Value, 2021–2032
6.7.2 South Korea Salvianolic Acid A Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Salvianolic Acid A Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Salvianolic Acid A Sales Value, 2021–2032
6.8.2 Southeast Asia Salvianolic Acid A Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Salvianolic Acid A Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Salvianolic Acid A Sales Value, 2021–2032
6.9.2 India Salvianolic Acid A Sales Value by Type (%), 2025 vs 2032
6.9.3 India Salvianolic Acid A Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Santa Cruz Biotechnology
7.1.1 Santa Cruz Biotechnology Company Information
7.1.2 Santa Cruz Biotechnology Introduction and Business Overview
7.1.3 Santa Cruz Biotechnology Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Santa Cruz Biotechnology Salvianolic Acid A Product Offerings
7.1.5 Santa Cruz Biotechnology Recent Developments
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Merck Salvianolic Acid A Product Offerings
7.2.5 Merck Recent Developments
7.3 Cayman Chemical
7.3.1 Cayman Chemical Company Information
7.3.2 Cayman Chemical Introduction and Business Overview
7.3.3 Cayman Chemical Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Cayman Chemical Salvianolic Acid A Product Offerings
7.3.5 Cayman Chemical Recent Developments
7.4 LGC
7.4.1 LGC Company Information
7.4.2 LGC Introduction and Business Overview
7.4.3 LGC Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 LGC Salvianolic Acid A Product Offerings
7.4.5 LGC Recent Developments
7.5 Adooq Bioscience
7.5.1 Adooq Bioscience Company Information
7.5.2 Adooq Bioscience Introduction and Business Overview
7.5.3 Adooq Bioscience Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Adooq Bioscience Salvianolic Acid A Product Offerings
7.5.5 Adooq Bioscience Recent Developments
7.6 Selleck Chemicals
7.6.1 Selleck Chemicals Company Information
7.6.2 Selleck Chemicals Introduction and Business Overview
7.6.3 Selleck Chemicals Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Selleck Chemicals Salvianolic Acid A Product Offerings
7.6.5 Selleck Chemicals Recent Developments
7.7 AbMole
7.7.1 AbMole Company Information
7.7.2 AbMole Introduction and Business Overview
7.7.3 AbMole Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 AbMole Salvianolic Acid A Product Offerings
7.7.5 AbMole Recent Developments
7.8 Ark Pharm
7.8.1 Ark Pharm Company Information
7.8.2 Ark Pharm Introduction and Business Overview
7.8.3 Ark Pharm Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Ark Pharm Salvianolic Acid A Product Offerings
7.8.5 Ark Pharm Recent Developments
7.9 Clearsynth
7.9.1 Clearsynth Company Information
7.9.2 Clearsynth Introduction and Business Overview
7.9.3 Clearsynth Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Clearsynth Salvianolic Acid A Product Offerings
7.9.5 Clearsynth Recent Developments
7.10 Biosynth Carbosynth
7.10.1 Biosynth Carbosynth Company Information
7.10.2 Biosynth Carbosynth Introduction and Business Overview
7.10.3 Biosynth Carbosynth Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Biosynth Carbosynth Salvianolic Acid A Product Offerings
7.10.5 Biosynth Carbosynth Recent Developments
7.11 Biorbyt
7.11.1 Biorbyt Company Information
7.11.2 Biorbyt Introduction and Business Overview
7.11.3 Biorbyt Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Biorbyt Salvianolic Acid A Product Offerings
7.11.5 Biorbyt Recent Developments
7.12 BOC Sciences
7.12.1 BOC Sciences Company Information
7.12.2 BOC Sciences Introduction and Business Overview
7.12.3 BOC Sciences Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 BOC Sciences Salvianolic Acid A Product Offerings
7.12.5 BOC Sciences Recent Developments
7.13 APExBIO Technology
7.13.1 APExBIO Technology Company Information
7.13.2 APExBIO Technology Introduction and Business Overview
7.13.3 APExBIO Technology Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 APExBIO Technology Salvianolic Acid A Product Offerings
7.13.5 APExBIO Technology Recent Developments
7.14 Aladdin
7.14.1 Aladdin Company Information
7.14.2 Aladdin Introduction and Business Overview
7.14.3 Aladdin Salvianolic Acid A Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Aladdin Salvianolic Acid A Product Offerings
7.14.5 Aladdin Recent Developments
8 Industry Chain Analysis
8.1 Salvianolic Acid A Industrial Chain
8.2 Salvianolic Acid A Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Salvianolic Acid A Sales Model
8.5.2 Sales Channels
8.5.3 Salvianolic Acid A Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Salvianolic Acid A market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 145
USD 2900.00
(Single User License)
The global Salvianolic Acid A market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 152
USD 4900.00
(Single User License)
The global market for Salvianolic Acid A was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 126
USD 3950.00
(Single User License)
The global market for Salvianolic Acid A was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 103
USD 2900.00
(Single User License)
The global Salvianolic Acid A market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 95
USD 4250.00
(Single User License)
Salvianolic acid A is a phenolic acid, isolated from Danshen, a traditional Chinese medicine, commonly used for the treatment of bone loss, chronic renal failure, hepatocirrhosis, hepatitis, coronary heart disease and cerebrovascular disease.
Published Date: 2024-04-07
Pages: 109
USD 4900.00
(Single User License)
Salvianolic acid A is a phenolic acid, isolated from Danshen, a traditional Chinese medicine, commonly used for the treatment of bone loss, chronic renal failure, hepatocirrhosis, hepatitis, coronary heart disease and cerebrovascular disease.
Published Date: 2024-02-19
Pages: 113
USD 3950.00
(Single User License)
Salvianolic acid A is a phenolic acid, isolated from Danshen, a traditional Chinese medicine, commonly used for the treatment of bone loss, chronic renal failure, hepatocirrhosis, hepatitis, coronary heart disease and cerebrovascular disease.
Published Date: 2024-01-12
Pages: 103
USD 2900.00
(Single User License)
The global Salvianolic Acid A market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 145
The global Salvianolic Acid A market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 152
The global market for Salvianolic Acid A was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 126
The global market for Salvianolic Acid A was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 103
The global Salvianolic Acid A market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 95
Salvianolic acid A is a phenolic acid, isolated from Danshen, a traditional Chinese medicine, commonly used for the treatment of bone loss, chronic renal failure, hepatocirrhosis, hepatitis, coronary heart disease and cerebrovascular disease.
Published: 2024-04-07
Pages: 109
Salvianolic acid A is a phenolic acid, isolated from Danshen, a traditional Chinese medicine, commonly used for the treatment of bone loss, chronic renal failure, hepatocirrhosis, hepatitis, coronary heart disease and cerebrovascular disease.
Published: 2024-02-19
Pages: 113
Salvianolic acid A is a phenolic acid, isolated from Danshen, a traditional Chinese medicine, commonly used for the treatment of bone loss, chronic renal failure, hepatocirrhosis, hepatitis, coronary heart disease and cerebrovascular disease.
Published: 2024-01-12
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now